Circulating tumor DNA to detect minimal residual disease, response to adjuvant therapy, and identify patients at high risk of recurrence in patients with stage I-III CRC.

Authors

null

Noelia Tarazona

Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Instituto de Salud Carlos III, CIBERONC, Valencia, Spain

Noelia Tarazona , Tenna V Henriksen , Juan Antonio Carbonell-Asins , Thomas Reinert , Shruti Sharma , Desamparados Roda , Svetlana Shchegrova , Marisol Huerta , Susana Roselló , Derrick Renner , Himanshu Sethi , Bernhard Zimmermann , Alexey Aleshin , Andres Cervantes , Claus Lindbjerg Andersen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Biologic Correlates

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4009)

DOI

10.1200/JCO.2020.38.15_suppl.4009

Abstract #

4009

Poster Bd #

1

Abstract Disclosures